Enhabit (EHAB) EVP Kalvaitis records 6,724-share stock grant in Form 4/A

Rhea-AI Filing Summary

Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported an amended Form 4 reflecting a prior stock award. She acquired 6,724 shares of common stock as a grant at a price of $13.61 per share. Following this acquisition, she directly holds 61,875 common shares. A footnote explains the award was omitted from the original filing due to a clerical error, and this amendment corrects that omission.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kalvaitis Jeanne Louise

Role EVP of Hospice Operations

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,724	$13.61	$92K

Holdings After Transaction: Common Stock — 61,875 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalvaitis Jeanne Louise

(Last) (First) (Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS TX 75206

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP of Hospice Operations

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		A		6,724(1)	A	$13.61	61,875	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Due to a clerical error, this award was omitted from the original filing.

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enhabit (EHAB) report for Jeanne Louise Kalvaitis?

Enhabit reported that EVP of Hospice Operations Jeanne Louise Kalvaitis acquired 6,724 shares of common stock. The shares were received as a grant at $13.61 per share and are recorded as a direct ownership position in her Form 4/A filing.

Is the Enhabit (EHAB) Form 4/A for Jeanne Kalvaitis a new transaction or a correction?

The Form 4/A is a correction, not a new trade. A footnote states the stock award was omitted from the original filing due to a clerical error, and this amendment updates the disclosure to include that previously granted award.

How many Enhabit (EHAB) shares does Jeanne Kalvaitis hold after the reported award?

After receiving the 6,724-share stock grant, Jeanne Kalvaitis directly holds 61,875 shares of Enhabit common stock. This total reflects her updated ownership position following inclusion of the previously omitted award in the amended Form 4/A.

Was Jeanne Kalvaitis’s Enhabit (EHAB) transaction an open-market purchase or a stock grant?

The transaction was a stock grant, not an open-market purchase. It is coded as an “A” transaction, described as a grant, award, or other acquisition, with 6,724 common shares received at a value of $13.61 per share.

What role does Jeanne Louise Kalvaitis hold at Enhabit (EHAB)?

Jeanne Louise Kalvaitis serves as Enhabit’s Executive Vice President of Hospice Operations. Her position is disclosed in the insider data, and the amended Form 4/A reports an equity award tied to her role as a company officer.